Guidance
Considerations for PCV product choice
This document summarizes current technical and programmatic information on WHO prequalified PCV
products to facilitate informed country choices for PCV introduction or product switch for childhood
immunization programmes.
Authors
Languages
- English
Publication year
2021
Type
Categories
Diseases
Organisations
PORTFOLIO-PCV
This resource appears in the following Hot Topic page:
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Considerations for PCV product choice | World Health Organization (WHO) | 2021 | Guidance | English |
| PCV catch-up vaccination FAQ | CHOICES | 2023 | Guidance | English, French |
| Pneumococcal Conjugate Vaccine (PCV) price data | UNICEF | 2023 | Datasheet | English |
| Pneumococcal conjugate vaccine cost calculator for Gavi-eligible countries | PATH | 2025 | Tool | English, French, Spanish |
| Pneumococcal conjugate vaccine cost calculator for middle-income countries | PATH | 2024 | Tool | English, French, Spanish |
| Vaccine Detailed product profiles (DPPs) For Gavi-supported vaccines | Gavi, the Vaccine Alliance | 2022 | Repository | English, French |
| VIEW-hub data on PCV introductions, coverage, and products | Johns Hopkins University, International Vaccine Access Center (IVAC) | 2000 | Tool | English |
| WHO position papers | World Health Organization (WHO) | Repository | Arabic, Chinese, English, French, Russian, Spanish | |
| WHO's Updated PCV Position Paper: 1p+1 Schedules for National Programs | Alejandro Ramirez Gonzalez, Eleanor Neal, Shamez Ladhani, Maya Vandenent, Johanna Fihman | 2026 | Webinar | English, French, Spanish |
